Paradoxical and bidirectional drug effects

Drug Safety

Volumn 35, Issue 3, 2012, Pages 173-189

  Smith, Silas W ^a,b   Hauben, Manfred ^c,d,e,f   Aronson, Jeffrey K ^g  

^a BELLEVUE HOSPITAL CENTER   (United States)

^b NEW YORK CITY POISON CONTROL CENTER   (United States)

^c PFIZER INC   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NEW YORK MEDICAL COLLEGE   (United States)

^f BRUNEL UNIVERSITY   (United Kingdom)

^g UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Paradoxical reaction; Pharmacology

Indexed keywords

ACECAINIDE; ACETYLCYSTEINE; AMIODARONE; ANTIBIOTIC AGENT; ANTIBODY; ANTIDEPRESSANT AGENT; ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIOVASCULAR AGENT; CELL RECEPTOR; CENTRAL NERVOUS SYSTEM AGENTS; DERMATOLOGICAL AGENT; DIURETIC AGENT; FLUMAZENIL; GASTROINTESTINAL AGENT; GLUCOSE; HYDROCHLOROTHIAZIDE; IMMUNOMODULATING AGENT; ISOPRENALINE; METHYLENE BLUE; MIDAZOLAM; NITRIC ACID DERIVATIVE; OPIATE DERIVATIVE; PARACETAMOL; PSYCHOTROPIC AGENT; SALBUTAMOL; SULFONYLUREA DERIVATIVE; SUXAMETHONIUM; UNINDEXED DRUG; XENOBIOTIC AGENT;

AGITATION; ALPHA ADRENERGIC RECEPTOR BLOCKING; ARTICLE; BRADYCARDIA; CELL COMPARTMENTALIZATION; DRUG EFFECT; DRUG SURVEILLANCE PROGRAM; FEEDBACK SYSTEM; HEART INFARCTION; HUMAN; LOW DRUG DOSE; LUNG EDEMA; NONLINEAR SYSTEM; OSCILLATION; PARADOXICAL DRUG REACTION; PHARMACODYNAMICS; PHARMACOKINETICS; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SIDE EFFECT; STEREOCHEMISTRY; SUICIDAL IDEATION;

DRUG RESISTANCE; DRUG THERAPY; HUMANS; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; PHARMACOLOGICAL PHENOMENA; PHARMACOLOGICAL PROCESSES; PHARMACOVIGILANCE;

EID: 84863169414     PISSN: 01145916     EISSN: 11791942     Source Type: Journal    
DOI: 10.2165/11597710-000000000-00000     Document Type: Article

References (165)

1. Turk EE. Hypothermia. Forensic Sci Med Pathol 2010; 6: 106-15
2. McKinney M, Arcasoy MO. Erythropoietin for oncology supportive care. Exp Cell Res 2011; 317: 1246-54
3. Bennett CL, Cournoyer D, Carson KR, et al. Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project. Blood 2005; 106: 3343-7 (Pubitemid 41609162)
4. Bate R, Milligan J, Mooney L. Dangerous substandard medicines: an increasing global problem. AEI Outlook Series, Number 6. Washington, DC. American Enterprise Institute for Public Policy Research, 2011
5. Centers for Disease Control and Prevention (CDC). Endotoxin-like reactions associated with intravenous gentamicin: California, 1998.MMWRMorb Mortal Wkly Rep 1998; 47: 877-80
6. Hauben M, Aronson JK. Defining 'signal' and its subtypes in pharmacovigilance based on a systematic review of previous definitions. Drug Saf 2009; 32: 99-110
7. Hauben M, Aronson JK. Paradoxical reactions: underrecognized adverse effects of drugs? [abstract]. Drug Saf 2006; 29: 970
8. ECC Committee, Subcommittees and Task Forces of the American Heart Association. 2005 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 2005; 112: IV1-203
9. Reeves RR, Ladner ME. Antidepressant-induced suicidality: an update. CNS Neurosci Ther 2010; 16: 227-34
10. Steinberg AD. Pulmonary edema following ingestion of hydrochlorothiazide. JAMA 1968; 204: 825-7
11. Aronson JK. Diuretics. In: Aronson JK, editor. Side effects of drugs annual 31. Amsterdam: Elsevier Science, 2009: 371-81
12. Boyle PJ, Justice K, Krentz AJ, et al. Octreotide reverses hyperinsulinemia and prevents hypoglycemia induced by sulfonylurea overdoses. J Clin Endocrinol Metab 1993; 76: 752-6 (Pubitemid 23086500)
13. Bond RA. Is paradoxical pharmacology a strategy worth pursuing? Trends Pharmacol Sci 2001; 22: 273-6 (Pubitemid 32523909)
14. Loffing J. Paradoxical antidiuretic effect of thiazides in diabetes insipidus: another piece in the puzzle. J Am Soc Nephrol 2004; 15: 2948-50 (Pubitemid 41103404)
15. Davies CJ, Davies DM. Paradoxical reactions to commonly used drugs. Adverse Drug React Bull 2001; 211: 807-10 (Pubitemid 34176817)
16. Page C. Paradoxical pharmacology: turning our pharmacological models upside down. Trends Pharmacol Sci 2011; 32: 197-200
17. Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2009 [online]. Available from URL: http://www.cochrane-hand book.org [Accessed 2011 Dec 7]
18. Mattson MP, Calabrese EJ, editors. Hormesis: a revolution in biology, toxicology and medicine. New York: Springer Science+Business Media, LLC, 2010
19. Kendig EL, Le HH, Belcher SM. Defining hormesis: evaluation of a complex concentration response phenomenon. Int J Toxicol 2010; 29: 235-46
20. Azzam EI. Exposure to low level environmental agents: the induction of hormesis. Mutat Res 2011; 726 (2): 89-90
21. Klaunig JE, Kamendulis LM. Chemical carcinogens. In: Klaassen CD, editor. Casarett and Doull's toxicology: the basic science of poisons. 7th ed. New York: The McGraw-Hill Companies, Inc., 2008: 329-79
22. Calabrese EJ, Bachmann KA, Bailer AJ, et al. Biological stress response terminology: Integrating the concepts of adaptive response and preconditioning stress within a hormetic dose-response framework. Toxicol Appl Pharmacol 2007; 222: 122-8 (Pubitemid 46970781)
23. Calabrese EJ. Hormesis is central to toxicology, pharmacology and risk assessment. Hum Exp Toxicol 2010; 29: 249-61
24. Calabrese EJ, Blain R. The occurrence of hormetic dose responses in the toxicological literature, the hormesis database: an overview. Toxicol Appl Pharmacol 2005; 202: 289-301 (Pubitemid 40164282)
25. Zhang Q, Andersen ME. Dose response relationship in anti-stress gene regulatory networks. PLoS Comput Biol 2007; 3: e24
26. Zhang Q, Pi J, Woods CG, et al. Phase I to II crossinduction of xenobiotic metabolizing enzymes: a feedforward control mechanism for potential hormetic responses. Toxicol Appl Pharmacol 2009; 237: 345-56
27. Kriete A, Bosl WJ, Booker G. Rule-based cell systems model of aging using feedback loop motifs mediated by stress responses. PLoS Comput Biol 2010; 6: e1000820
28. Millat T, Sreenath SN, Soebiyanto RP, et al. The role of dynamic stimulation pattern in the analysis of bistable intracellular networks. BioSystems 2008; 92: 270-81 (Pubitemid 351636191)
29. Szabadi E. A model of two functionally antagonistic receptor populations activated by the same agonist. J Theor Biol 1977; 69: 101-12 (Pubitemid 8215873)
30. Srivastava D, Yu S. Stretching to meet needs: integrinlinked kinase and the cardiac pump. Genes Dev 2006; 20: 2327-31 (Pubitemid 44320380)
31. Mathur AB, Collinsworth AM, Reichert WM, et al. Endothelial, cardiac muscle and skeletal muscle exhibit different viscous and elastic properties as determined by atomic force microscopy. J Biomech 2001; 34: 1545-53 (Pubitemid 33041370)
32. Yaniv Y, Sivan R, Landesberg A. Analysis of hystereses in force length and force calcium relations. Am J Physiol Heart Circ Physiol 2005; 288: H389-99 (Pubitemid 40023871)
33. Steimle KL, Mogensen ML, Karbing DS, et al. A model of ventilation of the healthy human lung. Comput Methods Programs Biomed 2011; 101: 144-55
34. Moller C, Arai N, Lucke J, et al. Hysteresis effects on the input-output curve of motor evoked potentials. Clin Neurophysiol 2009; 120: 1003-8
35. Kaltenbrunner A, Gomez V, Lopez V. Phase transition and hysteresis in an ensemble of stochastic spiking neurons. Neural Comput 2007; 19: 3011-50
36. Hogenesch JB, Ueda HR. Understanding systems-level properties: timely stories from the study of clocks. Nat Rev Genet 2011; 12: 407-16
37. Buonocore G, Perrone S, Tataranno ML. Oxygen toxicity: chemistry and biology of reactive oxygen species. Semin Fetal Neonatal Med 2010; 15: 186-90
38. Greabu M, Battino M, Mohora M, et al. Oxygen, a paradoxical element? Rom J Intern Med 2008; 46: 125-35
39. Gayatri NA, Livingston JH. Aggravation of epilepsy by anti-epileptic drugs.Dev Med Child Neurol 2006; 48: 394-8
40. Lee AC, Chan GC, Fung CF, et al. Paradoxical response of a pineal immature teratoma to combination chemotherapy. Med Pediatr Oncol 1995; 24: 53-7 (Pubitemid 24373612)
41. Chang HY, Lembo AJ. Opioid-induced bowel dysfunction. Curr Treat Options Gastroenterol 2008; 11: 11-8
42. Cohen RA, Pops MA. Paradoxical diarrhea with opiates. JAMA 1968; 205: 802-3
43. Graham LA, Gray JC, Kenny RA. Comparison of provocative tests for unexplained syncope: isoprenaline and glyceryl trinitrate for diagnosing vasovagal syncope. Eur Heart J 2001; 22: 497-503 (Pubitemid 32619623)
44. Jordan J, Tank J, Shannon JR, et al. Baroreflex buffering and susceptibility to vasoactive drugs. Circulation 2002; 105: 1459-64 (Pubitemid 34263278)
45. Brembilla-Perrot B, Muhanna I, Nippert M, et al. Paradoxical effect of isoprenaline infusion. Europace 2005; 7: 621-7 (Pubitemid 41488109)
46. Padmanabhan H. Amiodarone and thyroid dysfunction. South Med J 2010; 103: 922-30
47. Sandilands EA, Bateman DN. Adverse reactions associated with acetylcysteine. Clin Toxicol (Phila) 2009; 47: 81-8
48. Polc P. Electrophysiology of benzodiazepine receptor ligands: multiple mechanisms and sites of action. Prog Neurobiol 1988; 31: 349-423
49. D'Hulst C, Atack JR, Kooy RF. The complexity of the GABAA receptor shapes unique pharmacological profiles. Drug Discov Today 2009; 14: 866-75
50. Saxon L, Borg S, Hiltunen AJ. Reduction of aggression during benzodiazepine withdrawal: effects of flumazenil. Pharmacol Biochem Behav 2010; 96: 148-51
51. Taylor SH. Intrinsic sympathomimetic activity: clinical fact or fiction? Am J Cardiol 1983; 52: 16-26D (Pubitemid 14245075)
52. New evidence on xamoterol [editorial]. Lancet 1990; 336: 24
53. Vakily M, Mehvar R, Brocks D. Stereoselective pharmacokinetics and pharmacodynamics of anti-asthma agents. Ann Pharmacother 2002; 36: 693-701 (Pubitemid 34270288)
54. Leblanc M, Pichette V, Madore F, et al. N-acetylprocainamide intoxication with torsade de pointes treated by high dialysate flow rate continuous arteriovenous hemodiafiltration. Crit Care Med 1995; 23: 589-93
55. Ludmer PL, Selwyn AP, Shook TL, et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986; 315: 1046-51 (Pubitemid 17170620)
56. Cannard K. The acute treatment of nerve agent exposure. J Neurol Sci 2006; 249: 86-94 (Pubitemid 44665912)
57. Nazarian RM, Van Cott EM, Zembowicz A, et al. Warfarin-induced skin necrosis. J Am Acad Dermatol 2009; 61: 325-32
58. Boyd JH, Walley KR. Is there a role for sodium bicarbonate in treating lactic acidosis from shock? Curr Opin Crit Care 2008; 14: 379-83
59. Kirsten R, Nelson K, Kirsten D, et al. Clinical pharmacokinetics of vasodilators: part II. Clin Pharmacokinet 1998; 35: 9-36
60. International Programme on Chemical Safety. Organophosphorus pesticides. Poisons information monograph (group monograph) G001. Geneva: World Health Organization, 1989 (updated 1999) [online]. Available from URL: http://www.inchem.org/documents/pims/chemi cal/pimg001.htm [Accessed 2011 Dec 7]
61. Brown P, Eusebio A. paradoxes of functional neurosurgery: clues from basal ganglia recordings. Mov Disord 2008; 23: 12-20; quiz 158 (Pubitemid 351281212)
62. Stowe R, Ives N, Clarke CE, et al. Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson s disease patients with motor complications. Cochrane Database Syst Rev 2010; 7: CD007166
63. Jenkins JR, Pearce JM. Paradoxical akinetic response to apomorphine in parkinsonism. J Neurol Neurosurg Psychiatry 1992; 55: 414-5
64. Shu J, Zhou J, Patel C, et al. Pharmacotherapy of cardiac arrhythmias: basic science for clinicians. Pacing Clin Electrophysiol 2009; 32: 1454-65
65. Reinders MK, Jansen TL. Management of hyperuricemia in gout: focus on febuxostat. Clin Interv Aging 2010; 5: 7-18
66. El-Sheikh AA, van den Heuvel JJ, Koenderink JB, et al. Effect of hypouricaemic and hyperuricaemic drugs on the renal urate efflux transporter, multidrug resistance protein Br J Pharmacol 2008; 155: 1066-75
67. Koutsostathis N, Vovolis V. Severe immunoglobulin E-mediated anaphylaxis to intravenous methylprednisolone succinate in a patient who tolerated oral methylprednisolone. J Investig Allergol Clin Immunol 2009; 19: 330-2
68. Nahum A, Garty BZ, Marcus N, et al. Severe hypersensitivity reactions to corticosteroids in children. Pediatr Emerg Care 2009; 25: 339-41
69. Beatty GW. Immune reconstitution inflammatory syndrome. Emerg Med Clin North Am 2010; 28: 393-407
70. Sheehan JP. Fasting hyperglycemia: etiology, diagnosis, and treatment. Diabetes Technol Ther 2004; 6: 525-33 (Pubitemid 39121381)
71. Ghani MF, Parker BM. Hypotension, heart block and reversed pulsus alternans in a patient with hypertrophic subaortic stenosis following digitalis and diuretic therapy. Chest 1974; 65: 695-8
72. Maron BJ, Maron MS, Wigle ED, et al. The 50-year history, controversy, and clinical implications of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy: from idiopathic hypertrophic subaortic stenosis to hypertrophic cardiomyopathy. J Am Coll Cardiol 2009; 54: 191-200
73. Sacca S, Pascotto A, Siniscalchi C, et al. Ocular complications of latanoprost in uveitic glaucoma: three case reports. J Ocul Pharmacol Ther 2001; 17: 107-13 (Pubitemid 32299075)
74. Smith SW. Chiral toxicology: it's the same thing . only different. Toxicol Sci 2009; 110: 4-30
75. Leonov A, Bielory L. Chirality in ocular agents. Curr Opin Allergy Clin Immunol 2007; 7: 418-23 (Pubitemid 47415286)
76. Magdalan J, Merwid-Lad A, Sozanski T. Acute poisoning with moxonidine? A case report. Clin Toxicol (Phila) 2008; 46: 921-2
77. Zakarija A, Kwaan HC, Moake JL, et al. Ticlopidine-and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008). Kidney Int Suppl 2009; 75 Suppl. 112: S20-4
78. Chivot M. Acne flare-up and deterioration with oral isotretinoin. Ann Dermatol Venereol 2001; 128: 224-8 (Pubitemid 32298695)
79. Aloizos S, Gourgiotis S, Oikonomou K, et al. Recurrent Jarisch-Herxheimer reaction in a patient with Q fever pneumonia: a case report. Cases J 2008; 1: 360
80. Masoumi Asl H, Goya MM, Vatandoost H, et al. The epidemiology of tick-borne relapsing fever in Iran during 1997-2006. Travel Med Infect Dis 2009; 7: 160-4
81. Pound MW, May DB. Proposed mechanisms and preventative options of Jarisch-Herxheimer reactions. J Clin Pharm Ther 2005; 30: 291-5 (Pubitemid 41603054)
82. Navas E, Martin-Davila P, Moreno L, et al. Paradoxical reactions of tuberculosis in patients with the acquired immunodeficiency syndrome who are treated with highly active antiretroviral therapy. Arch Intern Med 2002; 162: 97-9 (Pubitemid 34073410)
83. Sheth A, Reddymasu S, Jackson R. Worsening of asthma with systemic corticosteroids: a case report and review of literature. J Gen Intern Med 2006; 21: C11-3 (Pubitemid 43363662)
84. Manni E, Barachini P. Psoriasis induced by infliximab in a patient suffering from Crohn's disease. Int J Immunopathol Pharmacol 2009; 22: 841-4
85. Aslanidis S, Pyrpasopoulou A, Douma S, et al. Tumor necrosis factor-a antagonist-induced psoriasis: yet another paradox in medicine. Clin Rheumatol 2008; 27: 377-80
86. Harrison MJ, Dixon WG, Watson KD, et al. Rates of newonset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register. Ann Rheum Dis 2009; 68: 209-15
87. Friedman DL, Whitton J, Leisenring W, et al. Subsequent neoplasms in 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study. J Natl Cancer Inst 2010; 102: 1083-95
88. Rahman MM, Ng JC, Naidu R. Chronic exposure of arsenic via drinking water and its adverse health impacts on humans. Environ Geochem Health 2009; 31 Suppl. 1: 189-200
89. Cui X, Kobayashi Y, Akashi M, et al. Metabolism and the paradoxical effects of arsenic: carcinogenesis and anticancer. Curr Med Chem 2008; 15: 2293-304
90. Neumar RW, Otto CW, Link MS, et al. Part 8: adult advanced cardiovascular life support. 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation 2010; 122: S729-67
91. Druz RS. Current advances in vasodilator pharmacological stress perfusion imaging. Semin Nucl Med 2009; 39: 204-9
92. Thadani U, Rodgers T. Side effects of using nitrates to treat angina. Expert Opin Drug Saf 2006; 5: 667-74 (Pubitemid 44322884)
93. Meredith PA, Ostergren J, Anand I, et al. Clinical outcomes according to baseline blood pressure in patients with a low ejection fraction in the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity) program. J Am Coll Cardiol 2008; 52: 2000-7
94. Oleesky DA, Mir MA. Paradoxical high-density lipoprotein reduction induced by fibrate therapy. Ann Clin Biochem 1997; 34 (Pt 5): 573-4 (Pubitemid 27379850)
95. Collinson PO, Hjelm CJ, Canepo-Anson R. Paradoxical high-density lipoprotein reduction induced by fenofibrate and ciprofibrate. Ann Clin Biochem 1996; 33 (Pt 2): 159-61 (Pubitemid 26121551)
96. Doherty E, Lumb PJ, Chik G, et al. Ezetimibe-induced hyperlipidaemia. Int J Clin Pract Suppl 2005; 59 Suppl. 147: 3-5 (Pubitemid 44890371)
97. Hawkins DJ, Unwin P. Paradoxical and severe hypotension in response to adrenaline infusions in massive quetiapine overdose. Crit Care Resusc 2008; 10: 320-2
98. Ho CY. Hypertrophic cardiomyopathy. Heart Fail Clin 2010; 6: 141-59
99. Bigal ME, Tepper SJ. Ergotamine and dihydroergotamine: a review. Curr Pain Headache Rep 2003; 7: 55-62 (Pubitemid 38915071)
100. Kraft W, Greenberg HE, Waldman SA. Paradoxical hypotension and bradycardia after intravenous arginine vasopressin. J Clin Pharmacol 1998; 38: 283-6 (Pubitemid 28144934)
101. Eilers H, Cattaruzza F, Nassini R, et al. Pungent general anesthetics activate transient receptor potential-A1 to produce hyperalgesia and neurogenic bronchoconstriction. Anesthesiology 2010; 112: 1452-63
102. Khattab AM, El-Seify ZA. Sevoflurane-emergence agitation: effect of supplementary low-dose oral ketamine premedication in preschool children undergoing dental surgery. Saudi J Anaesth 2009; 3: 61-6
103. Miner JR, Gray RO, Bahr J, et al. Randomized clinical trial of propofol versus ketamine for procedural sedation in the emergency department. Acad Emerg Med 2010; 17: 604-11
104. Kochen S, Giagante B, Oddo S. Spike-and-wave complexes and seizure exacerbation caused by carbamazepine. Eur J Neurol 2002; 9: 41-7
105. Szucs A, Clemens Z, Jakus R, et al. The risk of paradoxical levetiracetam effect is increased in mentally retarded patients. Epilepsia 2008; 49: 1174-9 (Pubitemid 351991396)
106. Bauer J. Seizure-inducing effects of antiepileptic drugs: a review. Acta Neurol Scand 1996; 94: 367-77 (Pubitemid 27026419)
107. de Leon J, Nikoloff DM. Paradoxical excitation on diphenhydramine may be associated with being a CYP2D6 ultrarapid metabolizer: three case reports. CNS Spectr 2008; 13: 133-5
108. Pragst F, Herre S, Bakdash A. Poisonings with diphenhydramine: a survey of 68 clinical and 55 death cases. Forensic Sci Int 2006; 161: 189-97 (Pubitemid 44150624)
109. Slatt KA. Crazy with chloral hydrate: a parent witnesses a paradoxical reaction. Gastroenterol Nurs 2009; 32: 296-7
110. Mancuso CE, Tanzi MG, Gabay M. Paradoxical reactions to benzodiazepines: literature review and treatment options. Pharmacotherapy 2004; 24: 1177-85 (Pubitemid 39128841)
111. Ginsburg BC, Martinez G, Friesenhahn G, et al. Acute tolerance to rate-decreasing effects of single doses of ethanol. Physiol Behav 2008; 94: 374-83 (Pubitemid 351680288)
112. Shochet RB, Murray GB. Analytic reviews: neuropsychiatric toxicity of meperidine. J Intensive Care Med 1988; 3: 246-52
113. Bannister K, Dickenson AH. Opioid hyperalgesia. Curr Opin Support Palliat Care 2010; 4: 1-5
114. Vanderah TW, Suenaga NM, Ossipov MH, et al. Tonic descending facilitation from the rostral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance. J Neurosci 2001; 21: 279-86 (Pubitemid 32098751)
115. Zahodne LB, Fernandez HH. Pathophysiology and treatment of psychosis in Parkinson's disease: a review. Drugs Aging 2008; 25: 665-82
116. Vernino S, Sandroni P, Singer W, et al. Autonomic ganglia: target and novel therapeutic tool. Neurology 2008; 70: 1926-32 (Pubitemid 351684647)
117. Jones VM, Moore KA, Peterson DM. Capsaicin 8%topical patch (Qutenza): a review of the evidence. J Pain Palliat Care Pharmacother 2011; 25: 32-41
118. Davenport A, Davison AM, Will EJ. The prognostic use of a lactate infusion in patients with severe hepatorenal failure. Ren Fail 1991; 13: 111-8
119. Kroll MH. Parathyroid hormone temporal effects on bone formation and resorption. Bull Math Biol 2000; 62: 163-88 (Pubitemid 30046418)
120. Chan SS, Rosenberg ZS, Chan K, et al. Subtrochanteric femoral fractures in patients receiving long-term alendronate therapy: imaging features. AJR Am J Roentgenol 2010; 194: 1581-6
121. Filleul O, Crompot E, Saussez S. Bisphosphonate-induced osteonecrosis of the jaw: a review of 2,400 patient cases. J Cancer Res Clin Oncol 2010; 136: 1117-24
122. Narayana VM, Lew SQ, Kimmel PL. Persistent hyponatremia ameliorated by discontinuation of hypertonic saline administration. J Appl Res 2004; 4: 261-5 (Pubitemid 39387304)
123. Joo Suk O. Paradoxical hypomagnesemia caused by excessive ingestion of magnesium hydroxide. Am J Emerg Med 2008; 26: 837.e1-2
124. Leow MK, Wyckoff J. Under-recognised paradox of neuropathy from rapid glycaemic control. Postgrad Med J 2005; 81: 103-7 (Pubitemid 40282874)
125. Rothchild I. The corpus luteum revisited: are the paradoxical effects of RU486 a clue to how progesterone stimulates its own secretion? Biol Reprod 1996; 55: 1-4 (Pubitemid 26293133)
126. French FS, Macfie JA, Baggett B, et al. Cushing's syndrome with a paradoxical response to dexamethasone. Am J Med 1969; 47: 619-24
127. Kane MP, Busch RS. Drug-induced thyrotoxic periodic paralysis. Ann Pharmacother 2006; 40: 778-81
128. Burgi H. Iodine excess. Best Pract Res Clin Endocrinol Metab 2010; 24: 107-15
129. Lazarus JH. Lithium and thyroid. Best Pract Res Clin Endocrinol Metab 2009; 23: 723-33
130. Ali S, Lally EV. Treatment failure gout. Med Health R I 2009; 92: 369-71
131. Rolny P, Arleback A, Funch-Jensen P, et al. Paradoxical response of sphincter of Oddi to intravenous injection of cholecystokinin or ceruletide: manometric findings and results of treatment in biliary dyskinesia. Gut 1986; 27: 1507-11 (Pubitemid 17218521)
132. Bennett CL, Luminari S, Nissenson AR, et al. Pure red-cell aplasia and epoetin therapy. N Engl J Med 2004; 351: 1403-8 (Pubitemid 39288166)
133. Weatherall M, Wijesinghe M, Perrin K, et al. Meta-analysis of the risk of mortality with salmeterol and the effect of concomitant inhaled corticosteroid therapy. Thorax 2010; 65: 39-43
134. Rodrigo GJ, Moral VP, Marcos LG, et al. Safety of regular use of long-acting beta agonists as monotherapy or added to inhaled corticosteroids in asthma: a systematic review. Pulm Pharmacol Ther 2009; 22: 9-19
135. Corrao G, Zambon A, Faini S, et al. Short-acting inhaled beta-2-agonists increased the mortality from chronic obstructive pulmonary disease in observational designs. J Clin Epidemiol 2005; 58: 92-7 (Pubitemid 40093117)
136. Saugstad OD. Resuscitation of newborn infants: from oxygen to room air. Lancet 2010; 376: 1970-1
137. Todes-Taylor N, Abel EA, Cox AJ. The occurrence of vitiligo after psoralens and ultraviolet a therapy. J Am Acad Dermatol 1983; 9: 526-32 (Pubitemid 13007748)
138. Rodriguez-Jimenez B, Dominguez-Ortega J, Gonzalez-Garcia JM, et al. Dimenhydrinate-induced fixed drug eruption in a patient who tolerated other antihistamines. J Investig Allergol Clin Immunol 2009; 19: 334-5
139. Cravo M, Goncalo M, Figueiredo A. Fixed drug eruption to cetirizine with positive lesional patch tests to the three piperazine derivatives. Int J Dermatol 2007; 46: 760-2 (Pubitemid 47046201)
140. Dwyer CM, Dick D. Fixed drug eruption caused by diphenhydramine. J Am Acad Dermatol 1993; 29: 496-7 (Pubitemid 23260148)
141. van Marum RJ, Wegewijs MA, Loonen AJ, et al. Hypothermia following antipsychotic drug use. Eur J Clin Pharmacol 2007; 63: 627-31 (Pubitemid 46684491)
142. Brent J, Vo N, Kulig K, et al. Reversal of prolonged isoniazid-induced coma by pyridoxine. Arch Intern Med 1990; 150: 1751-3 (Pubitemid 20240993)
143. Wason S, Lacouture PG, Lovejoy Jr FH. Single high-dose pyridoxine treatment for isoniazid overdose. JAMA 1981; 246: 1102-4 (Pubitemid 11051854)
144. Rudolph T, Knudsen K. A case of fatal caffeine poisoning. Acta Anaesthesiol Scand 2010; 54: 521-3
145. Tarka Jr SM. The toxicology of cocoa and methylxanthines: a review of the literature. Crit Rev Toxicol 1982; 9: 275-312
146. Candy JM, Morrison C, Paton RD, et al. Salicylate toxicity masquerading as malignant hyperthermia. Paediatr Anaesth 1998; 8: 421-3 (Pubitemid 28385507)
147. Handa PK, Tai DY. Carbon monoxide poisoning: a five year review at Tan Tock Seng Hospital, Singapore. Ann Acad Med Singapore 2005; 34: 611-4
148. Kao LW, Nanagas KA. Carbon monoxide poisoning. Med Clin North Am 2005; 89: 1161-94 (Pubitemid 41446567)
149. Doujaiji B, Al-Tawfiq JA. Hydrogen sulfide exposure in an adult male. Ann Saudi Med 2010; 30: 76-80
150. Walker Jr B. Neurotoxicity in human beings. J Lab Clin Med 2000; 136: 168-80
151. Lorenc JD. Inhalant abuse in the pediatric population: a persistent challenge. Curr Opin Pediatr 2003; 15: 204-9 (Pubitemid 36337834)
152. Reese E, Kimbrough RD. Acute toxicity of gasoline and some additives. Environ Health Perspect 1993; 101 Suppl. 6: 115-31 (Pubitemid 24075485)
153. Johnson D, Kubic P, Levitt C. Accidental ingestion of Vacor rodenticide: the symptoms and sequelae in a 25-month-old child. Am J Dis Child 1980; 134: 161-4 (Pubitemid 10129365)
154. Leung NY, Whyte IM, Isbister GK. Baclofen overdose: defining the spectrum of toxicity. Emerg Med Australas 2006; 18: 77-82
155. Ross JC, Cook AM, Stewart GL, et al. Acute intrathecal baclofen withdrawal: a brief review of treatment options. Neurocrit Care 2011; 14: 103-8
156. Duberstein JL, Kaufman DM. A clinical study of an epidemic of heroin intoxication and heroin-induced pulmonary edema. Am J Med 1971; 51: 704-14
157. Helpern M, Rho YM. Deaths from narcotism in New York City: incidence, circumstances, and postmortem findings. N Y State J Med 1966; 66: 2391-408
158. Mills CA, Flacke JW, Miller JD, et al. Cardiovascular effects of fentanyl reversal by naloxone at varying arterial carbon dioxide tensions in dogs. Anesth Analg 1988; 67: 730-6
159. Haddad PM, Dursun SM. Neurological complications of psychiatric drugs: clinical features and management. Hum Psychopharmacol 2008; 23 Suppl. 1: 15-26 (Pubitemid 351166609)
160. Kotzalidis GD, de Pisa E, Patrizi B, et al. Similar discontinuation symptoms for withdrawal from mediumdose paroxetine and venlafaxine after nine years in the same patient. J Psychopharmacol 2008; 22: 581-4
161. Gentile S. Serotonin reuptake inhibitor-induced perinatal complications. Paediatr Drugs 2007; 9: 97-106 (Pubitemid 46624562)
162. Skugor M, Siraj ES. A diabetic woman with worsening heart failure, hunger, and tremor. Cleve Clin J Med 2003; 70: 882-8 (Pubitemid 37304248)
163. Blass N, Fung D. Dyed but not dead: methylene blue overdose. Anesthesiology 1976; 45: 458-9
164. Whitwam JG, Taylor AR, White JM. Potential hazard of methylene blue. Anaesthesia 1979; 34: 181-2 (Pubitemid 9154083)
165. Khan NU, Wayne CK, Barker J, et al. The effects of protamine overdose on coagulation parameters as measured by the thrombelastograph. Eur J Anaesthesiol 2010; 27: 624-7